Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Biomaterials. 2023 Mar 17;296:122093. doi: 10.1016/j.biomaterials.2023.122093

Fig. 2.

Fig. 2.

Role of the mitotic spindle checkpoint in the cellular response to the therapeutic combination of PTX + CIP2b following the cell cycle analysis using ModFit LT software. (a, b, c, and d) Histograms of Ishikawa–H WTp53, Hec50co LOFp53, Hec50co GOFp53, and KLE GOFp53 cells, respectively, with indicated treatments represent cell cycle phases: G0/G1, S, and G2/M. (e, f, g, and h) Distribution of Ishikawa–H WTp53, Hec50co LOFp53, Hec50co GOFp53, and KLE GOFp53 cells, respectively, in each stage of the cell cycle after incubation with the indicated treatment for 24 hours. Data are plotted as mean ± SD (n=3).